Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2001, p. 3122-3127, Vol. 45, No. 11
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3122-3127.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Association of Genetic Mutations in
Plasmodium vivax dhfr with Resistance to
Sulfadoxine-Pyrimethamine: Geographical and Clinical
Correlates
Mallika
Imwong,1
Sasithon
Pukrittakayamee,1
Sornchai
Looareesuwan,1
Geoffrey
Pasvol,2
Jean
Poirreiz,3
Nicholas J.
White,1,4,* and
Georges
Snounou5
Faculty of Tropical Medicine, Mahidol University, Bangkok,
Thailand1; Department of Infection and
Tropical Medicine, Imperial College School of Medicine, Northwick
Park Hospital, Harrow,2 and Centre for
Tropical Medicine, Nuffield Department of Clinical Medicine, John
Radcliffe Hospital, Oxford,4 United Kingdom;
and Laboratoire de Biologie, Centre Hospitalier,
Dunkerque,3 and Unité de
Parasitologie Bio-Médicale, Institut Pasteur, 75724 Paris
Cedex 15,5 France
Received 30 April 2001/Returned for modification 19 July
2001/Accepted 15 August 2001
Mutations in the Plasmodium falciparum gene
(dhfr) encoding dihydrofolate reductase are associated with
resistance to antifols. Plasmodium vivax, the more
prevalent malaria parasite in Asia and the Americas, is considered
antifol resistant. Functional polymorphisms in the dhfr
gene of P. vivax (pvdhfr) were assessed by
PCR-restriction fragment length polymorphism using blood samples taken
from 125 patients with acute vivax malaria from three widely separated
locations, Thailand (n = 100), India
(n = 16), and Madagascar and the Comoros Islands
(n = 9). Upon evaluation of the three important codons
(encoding residues 57, 58, and 117) of P. vivax dhfr
(pvdhfr), double- or triple-mutation genotypes were found in all but one case from Thailand (99%), in only three cases from India (19%) and in no cases from Madagascar or the Comoros Islands (P < 0.0001). The dhfr PCR products
of P. vivax from 32 Thai patients treated with the
antifolate sulfadoxine-pyrimethamine (S-P) were investigated. All
samples showed either double (53%) or triple (47%) mutations.
Following treatment, 34% of the patients had early treatment failures
and only 10 (31%) of the patients cleared their parasitemias for 28 days. There were no significant differences in cure rates, but parasite
reduction ratios at 48 h were significantly lower for patients whose
samples showed triple mutations than for those whose samples showed
double mutations (P = 0.01). The three mutations at
the pvdhfr codons for residues 57, 58, and 117 are
associated with high levels of S-P resistance in P. vivax. These mutations presumably arose from selection pressure.
*
Corresponding author. Mailing address: Faculty of
Tropical Medicine, Mahidol University, 420/6 Rajvithi Rd., Bangkok
10400, Thailand. Phone: 66-2-246-0832. Fax: 66-2-246-7795. E-mail: fnnjw{at}diamond.mahidol.ac.th.
Antimicrobial Agents and Chemotherapy, November 2001, p. 3122-3127, Vol. 45, No. 11
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3122-3127.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rungsihirunrat, K., Sibley, C. H., Mungthin, M., Na-Bangchang, K.
(2008). Geographical Distribution of Amino Acid Mutations in Plasmodium vivax DHFR and DHPS from Malaria Endemic Areas of Thailand. Am J Trop Med Hyg
78: 462-467
[Abstract]
[Full Text]
-
Vestergaard, L. S., Ringwald, P.
(2007). Responding to the Challenge of Antimalarial Drug Resistance by Routine Monitoring to Update National Malaria Treatment Policies. Am J Trop Med Hyg
77: 153-159
[Abstract]
[Full Text]
-
Edstein, M. D., Kotecka, B. M., Ager, A. L., Smith, K. S., DiTusa, C. A., Diaz, D. S., Kyle, D. E., Schiehser, G. A., Jacobus, D. P., Rieckmann, K. H., O'Neil, M. T.
(2007). Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate JPC2056 in cynomolgus monkeys using an in vivo in vitro model. J Antimicrob Chemother
60: 811-818
[Abstract]
[Full Text]
-
Tanomsing, N., Imwong, M., Pukrittayakamee, S., Chotivanich, K., Looareesuwan, S., Mayxay, M., Dolecek, C., Hien, T. T., do Rosario, V. E., Arez, A. P., Michon, P., Snounou, G., White, N. J., Day, N. P. J.
(2007). Genetic Analysis of the Dihydrofolate Reductase-Thymidylate Synthase Gene from Geographically Diverse Isolates of Plasmodium malariae. Antimicrob. Agents Chemother.
51: 3523-3530
[Abstract]
[Full Text]
-
RUNGSIHIRUNRAT, K., NA-BANGCHANG, K., HAWKINS, V. N., MUNGTHIN, M., SIBLEY, C. H.
(2007). SENSITIVITY TO ANTIFOLATES AND GENETIC ANALYSIS OF PLASMODIUM VIVAX ISOLATES FROM THAILAND. Am J Trop Med Hyg
76: 1057-1065
[Abstract]
[Full Text]
-
Leslie, T., Mayan, M. I., Hasan, M. A., Safi, M. H., Klinkenberg, E., Whitty, C. J. M., Rowland, M.
(2007). Sulfadoxine-Pyrimethamine, Chlorproguanil-Dapsone, or Chloroquine for the Treatment of Plasmodium vivax Malaria in Afghanistan and Pakistan: A Randomized Controlled Trial. JAMA
297: 2201-2209
[Abstract]
[Full Text]
-
Gunasekera, A. M., Wickramarachchi, T., Neafsey, D. E., Ganguli, I., Perera, L., Premaratne, P. H., Hartl, D., Handunnetti, S. M., Udagama-Randeniya, P. V., Wirth, D. F.
(2007). Genetic Diversity and Selection at the Plasmodium vivax Apical Membrane Antigen-1 (PvAMA-1) Locus in a Sri Lankan Population. Mol Biol Evol
24: 939-947
[Abstract]
[Full Text]
-
Alam, M. T., Bora, H., Bharti, P. K., Saifi, M. A., Das, M. K., Dev, V., Kumar, A., Singh, N., Dash, A. P., Das, B., Wajihullah, , Sharma, Y. D.
(2007). Similar Trends of Pyrimethamine Resistance-Associated Mutations in Plasmodium vivax and P. falciparum. Antimicrob. Agents Chemother.
51: 857-863
[Abstract]
[Full Text]
-
AULIFF, A., WILSON, D. W., RUSSELL, B., GAO, Q., CHEN, N., ANH, L. N., MAGUIRE, J., BELL, D., O'NEIL, M. T., CHENG, Q.
(2006). AMINO ACID MUTATIONS IN PLASMODIUM VIVAX DHFR AND DHPS FROM SEVERAL GEOGRAPHICAL REGIONS AND SUSCEPTIBILITY TO ANTIFOLATE DRUGS.. Am J Trop Med Hyg
75: 617-621
[Abstract]
[Full Text]
-
Imwong, M., Pukrittayakamee, S., Cheng, Q., Moore, C., Looareesuwan, S., Snounou, G., White, N. J., Day, N. P. J.
(2005). Limited Polymorphism in the Dihydropteroate Synthetase Gene (dhps) of Plasmodium vivax Isolates from Thailand. Antimicrob. Agents Chemother.
49: 4393-4395
[Abstract]
[Full Text]
-
Kongsaeree, P., Khongsuk, P., Leartsakulpanich, U., Chitnumsub, P., Tarnchompoo, B., Walkinshaw, M. D., Yuthavong, Y.
(2005). Crystal structure of dihydrofolate reductase from Plasmodium vivax: Pyrimethamine displacement linked with mutation-induced resistance. Proc. Natl. Acad. Sci. USA
102: 13046-13051
[Abstract]
[Full Text]
-
Hastings, M. D., Maguire, J. D., Bangs, M. J., Zimmerman, P. A., Reeder, J. C., Baird, J. K., Sibley, C. H.
(2005). Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System. Antimicrob. Agents Chemother.
49: 733-740
[Abstract]
[Full Text]
-
Brega, S., de Monbrison, F., Severini, C., Udomsangpetch, R., Sutanto, I., Ruckert, P., Peyron, F., Picot, S.
(2004). Real-Time PCR for Dihydrofolate Reductase Gene Single-Nucleotide Polymorphisms in Plasmodium vivax Isolates. Antimicrob. Agents Chemother.
48: 2581-2587
[Abstract]
[Full Text]
-
Imwong, M., Pukrittayakamee, S., Renia, L., Letourneur, F., Charlieu, J.-P., Leartsakulpanich, U., Looareesuwan, S., White, N. J., Snounou, G.
(2003). Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax: Evidence for Sequential Selection by Drug Pressure. Antimicrob. Agents Chemother.
47: 1514-1521
[Abstract]
[Full Text]
-
Russell, B. M., Udomsangpetch, R., Rieckmann, K. H., Kotecka, B. M., Coleman, R. E., Sattabongkot, J.
(2003). Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic. Antimicrob. Agents Chemother.
47: 170-173
[Abstract]
[Full Text]
-
Tjitra, E., Baker, J., Suprianto, S., Cheng, Q., Anstey, N. M.
(2002). Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations. Antimicrob. Agents Chemother.
46: 3947-3953
[Abstract]
[Full Text]
-
Ridley, R. G.
(2002). Chemotherapeutic hope on the horizon for Plasmodium vivax malaria?. Proc. Natl. Acad. Sci. USA
99: 13362-13364
[Full Text]
-
Hastings, M. D., Sibley, C. H.
(2002). Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc. Natl. Acad. Sci. USA
99: 13137-13141
[Abstract]
[Full Text]